Reckitt Benckiser Pharmaceuticals Inc. / Medical Specialties / /
Country
United States / /
Currency
USD / /
Event
Product Issues / Product Recall / /
IndustryTerm
AIDS treatment / case management / Treatment for Parkinson’s disease / HIV treatment / positive social support networks / chemical / ancillary services / chemicals / /
MedicalCondition
HIV / constricted pupils / Disulfiram Alcohol abuse / nausea / severe mental disorders / drug dependence / only mild withdrawal symptoms / diarrhea / hepatitis / MS / thyroid dysfunction / head injury / opioid withdrawal symptoms / little respiratory depression / less respiratory depression / chronic buprenorphine-treated subjects / chronic depression / pain / mild withdrawal symptoms / less severe withdrawal symptoms / Opiate Addiction / infectious diseases / HIV/AIDS / respiratory depression / abdominal cramps / opioid withdrawal syndrome / withdrawal symptoms / Naltrexone Alcohol abuse / /
Center for Substance Abuse Treatment / U.S. Department of Health and Human Services / American Board of Medical Specialties / American Osteopathic Association / Health Services Administration / American Society of Addiction Medicine / American Psychiatric Association / U.S. Department of Justice / U.S. Food and Drug Administration / Johns Hopkins University School of Medicine Baltimore / Substance Abuse and Mental Health Services Administration / /
Practical considerations for the use of Buprenorphine (suboxone subutex)